Financial Statements — UGP
Balance Sheet
(in billions BRL)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Cash & Equivalents | 2.07 | 5.93 | 5.62 | 2.28 | 2.66 | 2.12 |
| Inventory | 3.92 | 4.29 | 4.91 | 3.92 | 3.85 | 3.72 |
| Total Current Assets | 16.05 | 18.65 | 18.56 | 25.02 | 17.49 | 15.06 |
| Total Non-current Assets | 23.51 | 19.60 | 17.88 | 13.99 | 18.76 | 16.14 |
| Total Assets | 39.56 | 38.25 | 36.44 | 39.01 | 36.25 | 31.20 |
| Total Current Liabilities | 10.49 | 11.23 | 12.77 | 12.64 | 9.24 | 5.20 |
| Total Non-current Liabilities | 13.24 | 12.99 | 11.50 | 15.90 | 17.10 | 16.17 |
| Total Liabilities* | 23.73 | 24.22 | 24.27 | 28.54 | 26.34 | 21.36 |
| Total Stockholder Equity | 15.82 | 14.03 | 12.17 | 10.47 | 9.91 | 9.84 |
* Derived from reported values
Income Statement
(in billions BRL) (except per-share rows)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Total Revenue | 133.50 | 126.05 | 143.63 | 109.73 | 81.24 | 89.30 |
| Cost of Revenue* | 123.81 | 116.73 | 136.28 | 104.83 | 75.63 | 83.19 |
| Gross Profit | 9.69 | 9.32 | 7.36 | 4.90 | 5.61 | 6.11 |
| Research & Development | -- | -- | -- | -- | 0.06 | 0.06 |
| Selling, General & Admin | 1.87 | 2.02 | 1.53 | 1.47 | 0.01 | 0.01 |
| Pretax Income | 4.01 | 3.58 | 1.88 | 1.01 | 1.50 | 0.78 |
| Tax Provision | 1.49 | 1.06 | 0.34 | 0.19 | -- | -- |
| Net Income | 2.53 | 2.52 | 1.84 | 0.88 | 0.93 | 0.40 |
| Basic EPS | 2.14 | 2.23 | 1.65 | 0.78 | 0.82 | 0.34 |
| Diluted EPS | 2.11 | 2.21 | 1.64 | 0.78 | 0.82 | 0.34 |
* Derived from reported values
Cash Flow Statement
(in billions BRL)| Metric | FY
2024 | FY
2023 | FY
2022 | FY
2021 | FY
2020 | FY
2019 |
|---|
| Operating Cash Flow | 3.74 | 3.85 | 2.00 | 2.59 | 3.14 | 2.92 |
| Investing Cash Flow | (6.39) | (1.02) | 7.90 | 0.72 | (2.14) | (1.84) |
| Financing Cash Flow | (1.23) | (2.49) | (6.91) | (3.36) | (0.59) | (2.92) |
